Halozyme's total assets for Q2 2025 were $2.05B, a decrease of -6.49% from the previous quarter. HALO total liabilities were $1.72B for the fiscal quarter, a 0.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.